Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study

Effects of Dipeptidyl Peptidase-4 Inhibitors on Hyperglycemia and Blood Cyclosporine Levels in Renal Transplant Patients with Diabetes: A Pilot Study

BackgroundThe use of dipeptidyl peptidase-4 (DPP-4) inhibitors is increasing among renal transplant patients with diabetes. However, the glucose-lowering efficacies of various DPP-4 inhibitors and their effects on blood cyclosporine levels have not been fully investigated. We compared the glucose-lo...

Full description

Bibliographic Details
Main Authors: Jaehyun Bae, Min Jung Lee, Eun Yeong Choe, Chang Hee Jung, Hye Jin Wang, Myoung Soo Kim, Yu Seun Kim, Joong-Yeol Park, Eun Seok Kang
Format: Article
Language:English
Published: Academya Publishing Co. 2016-03-01
Series:Endocrinology and Metabolism
Subjects:
Dipeptidyl-peptidase IV inhibitors
Sitagliptin phosphate
Vildagliptin
Linagliptin
Cyclosporine
Kidney transplantation
Diabetes mellitus
Online Access:http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-31-161.pdf

Internet

http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-31-161.pdf

Similar Items